AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (November 14, 2006). doi:10.1152/ajpendo.00300.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/3/E812    most recent
00300.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cade, W. T.
Right arrow Articles by Yarasheski, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cade, W. T.
Right arrow Articles by Yarasheski, K. E.
Submitted on June 22, 2006
Accepted on November 10, 2006

Blunted lipolysis and fatty acid oxidation during moderate exercise in HIV-infected subjects taking HAART

William Todd Cade1*, Dominic N. Reeds2, Bettina Mittendorfer3, Bruce W. Patterson4, William G Powderly4, Samuel Klein4, and Kevin E. Yarasheski4

1 Medicine, Washington University School of Medicine, St. Louis, Missouri, United States; Physical Therapy, Washington University School of Medicine, St. Louis, Missouri, United States
2 Washington University School of Medicine; Washington University School of Medicine, United States
3 Medicine, Washington University School of Medicine, St. Louis, Missouri, United States
4 Medicine, Washington University School of Medicine, St. Louis,, Missouri, United States

* To whom correspondence should be addressed. E-mail: tcade{at}im.wustl.edu.

Background: The protease inhibitor (PI) ritonavir (RTV) has been associated with elevated resting lipolytic rate, hyperlipidemia and insulin resistance/glucose intolerance. The purpose of this study was to examine relationships between lipolysis and fatty acid oxidation during rest, moderate exercise and recovery and measures of insulin sensitivity/glucose tolerance and fat redistribution in HIV+ subjects taking RTV (n=12), taking HAART but no PI (n=10) and HIV-seronegative controls (n=10). Methods: Stable isotope tracers [1-13C]palmitate and [1,1,2,3,3-2H5]glycerol were continuously infused with blood and breath collection during 1-hr rest, 70min submaximal exercise (50% VO2peak) and 1-hr recovery. Body composition was evaluated using DEXA, MRI and MRS, and 2-hr oral glucose tolerance tests with insulin monitoring were used to evaluate glucose tolerance and insulin resistance. Results: Lipolytic and FA oxidation rates were similar during rest and recovery in all groups, however were lower during moderate exercise in both HIV-infected groups (Glycerol Ra: HIV+RTV: 5.1 ± 1.2 vs. HIV+noPI: 5.9 ± 2.8 vs. Cntl: 7.4 ± 2.2 µmol/kgFFM/min, Palmitate oxidation: HIV+RTV: 1.6 ± 0.8 vs. HIV+noPI: 1.6 ± 0.8 vs. Cntl: 2.5 ± 1.7 µmol/kgFFM/min, p<0.01). Fasting and orally challenged glucose and insulin values were similar among groups. Conclusions: Lipolytic and FA oxidation rates were blunted during moderate exercise in HIV+ subjects taking HAART. Lower FA oxidation during exercise was primarily due to impaired plasma FA oxidation with a minor contribution from lower non-plasma FA oxidation. Regional differences in adipose tissue lipolysis during rest and moderate exercise may be important in HIV, and warrant further study.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.